信号转导
大麻素受体
大麻素
受体
功能选择性
兴奋剂
信号通路
内大麻素系统
神经科学
G蛋白偶联受体
生物
细胞生物学
化学
生物化学
作者
Mikkel Søes Ibsen,Mark A. Connor,Michelle Glass
标识
DOI:10.1089/can.2016.0037
摘要
An agonist that acts through a single receptor can activate numerous signaling pathways. Recent studies have suggested that different ligands can differentially activate these pathways by stabilizing a limited range of receptor conformations, which in turn preferentially drive different downstream signaling cascades. This concept, termed “biased signaling” represents an exciting therapeutic opportunity to target specific pathways that elicit only desired effects, while avoiding undesired effects mediated by different signaling cascades. The cannabinoid receptors CB1 and CB2 each activate multiple pathways, and evidence is emerging for bias within these pathways. This review will summarize the current evidence for biased signaling through cannabinoid receptor subtypes CB1 and CB2.
科研通智能强力驱动
Strongly Powered by AbleSci AI